… -microbiota interactions, and consequently modulates the disease development. Finally, we
shed light on the possible therapeutic approaches of IBD through targeting gut microbiome. …

… Inflammatory bowel diseases (IBDs) are systemic diseases … asymptomatic gut inflammation;
25% might develop overt IBD … rats do not develop gut or joint inflammation, suggesting that …

… societies and sharp rise of IBD in developing countries also suggest that Westernisation
of diet and environment influences disease development.3 Further, in immigrants who move …

Inflammatory bowel disease (IBD) is a chronic and life-long disease characterized by
gastrointestinal tract inflammation. It is caused by the interplay of the host’s genetic predisposition …

… Inflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing inflammatory
diseases of … facilitated therapeutic development. UC and CD display heterogeneity in …

… for the development of colorectal cancer (CRC) have been identified and well established.
Inflammatory bowel diseases (IBD) are confirmed as significant factor in development of CRC, …

Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis,
has become increasingly prevalent worldwide in the past decade. The nutritional status of …

… and inducible T regulatory cells, it facilitates the development of Th1 cells [47,48]. IL-2 facilitates
T regulatory cell formation but constrains Th17 development [49]. IL-33 also supports the …

… inflammatory bowel disease (IBD). Population-based data from patients with ulcerative colitis
(… and chronic inflammation play a crucial role in the development of CAC. The link between …

… in 982,240 patients with inflammatory bowel disease, inflammatory bowel disease was found
to be … Patients with inflammatory bowel disease are at risk of developing cardiovascular …